arcadia

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE1696.108.35 (+0.49 %)
PREV CLOSE ( ) 1687.75
OPEN PRICE ( ) 1711.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1696.10 (3)
VOLUME 1967
TODAY'S LOW / HIGH ( )1688.00 1727.40
52 WK LOW / HIGH ( )920 1960
NSE1694.303.1 (+0.18 %)
PREV CLOSE( ) 1691.20
OPEN PRICE ( ) 1701.40
BID PRICE (QTY) 1694.30 (41)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12007
TODAY'S LOW / HIGH( ) 1681.55 1740.35
52 WK LOW / HIGH ( )919.95 1960
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 11-07 1979
Management Info
Narayan K Seshadri - Chairman Gagan Singh Bedi - Managing Director
Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE, MCX
NEWS
12Sep Shareholder Meeting / Postal Ballot-O
In relation to the 39th Annual General Meeting of the Company held on Se..
12Sep Disclosure of Voting results of AGM (
AstraZeneca Pharma India Ltd has informed BSE regarding the details of V..
17Aug AstraZeneca Pharma receives marketing
AstraZeneca Pharma India has received Import & Market permission for..
17Aug AstraZeneca Pharma surges on receiving
Astrazeneca Pharma India is currently trading at Rs. 1750.00, up by 39.7..
17Aug Astrazeneca Receives Marketing Permis
This is to inform that AstraZeneca Pharma India Limited has received Imp..
Financials
Rs. in Millions
QTR Jun 18 ANNUAL 18
Net Profit63.93259.15
Gross Profit 91.52 438
Operating Profit 127.02585.38
Net Sales 1614.375719.89
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Piramal Enterprises (BSE)
 2329.00 (3.45%)
M.Cap ( in Cr)42227.38
TTK Healthcare (BSE)
 961.25 (7.33%)
M.Cap ( in Cr)1358.28
Merck (BSE)
 3058.30 (1.19%)
M.Cap ( in Cr)5076.59
Jenburkt Pharma (BSE)
 672.25 (4.85%)
M.Cap ( in Cr)308.52
Natco Pharma (BSE)
 740.55 (3.28%)
M.Cap ( in Cr)13673.10
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 18.75%
MUTUAL FUNDS/UTI 5.73%
FI/BANKS/INSURANCE 0.07%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM